Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Cervical Cancer

  Free Subscription


1 Acta Biochim Pol
1 Anticancer Agents Med Chem
2 Anticancer Res
2 Bioengineered
1 BMC Public Health
1 BMC Womens Health
1 Cancer Causes Control
2 Cancer Cell Int
1 Cancer Manag Res
1 Cell Cycle
2 Ecancermedicalscience
1 Front Cell Dev Biol
1 Front Cell Infect Microbiol
3 Front Oncol
1 Front Public Health
2 Gynecol Oncol
1 Health Commun
1 Hum Reprod
11 Hum Vaccin Immunother
1 Indian J Gynecol Oncol
1 Int J Clin Oncol
1 Int J Gynecol Cancer
1 J Cancer
1 J Clin Microbiol
1 J Med Screen
1 J Microbiol Biotechnol
1 J Minim Invasive Gynecol
1 J Nanosci Nanotechnol
3 J Obstet Gynaecol Res
1 J Oncol
1 J Pharm Pharmacol
1 Lancet Public Health
1 Nan Fang Yi Ke Da Xue Xue Bao
1 Oxid Med Cell Longev
1 Panminerva Med
1 PLoS One
7 Prev Med
1 Prev Med Rep
1 Public Health Nurs
1 Reprod Health
1 Sci Rep
1 Support Care Cancer
1 Tohoku J Exp Med
1 Tumori
2 Vaccine
1 Womens Health (Lond)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Biochim Pol

  1. YU MM, Wang GJ, Wu KH, Xue SL, et al
    MicroRNA-373-3p inhibits the growth of cervical cancer by targeting AKT1 both in vitro and in vivo.
    Acta Biochim Pol. 2021 Jul 8. pii: 5446. doi: 10.18388/abp.2020_5446.
    PubMed         Abstract available

    Anticancer Agents Med Chem

  2. LIU Y, Fu H, Zuo L
    Synergistic Cytotoxicity Effect of 5-fluorouracil and SHP2 Inhibitor Demethylincisterol A3 on Cervical Cancer Cell.
    Anticancer Agents Med Chem. 2021 Jul 8. pii: ACAMC-EPUB-116578.
    PubMed         Abstract available

    Anticancer Res

  3. SHAM N, Qin C, Zhu Z, Redington CG, et al
    Raspberry Extract With Potential Antitumor Activity Against Cervical Cancer.
    Anticancer Res. 2021;41:3343-3348.
    PubMed         Abstract available

  4. KIESEL M, Sauer S, Lob S, Herbert SL, et al
    Total Mesometrial Resection With (Neo)Adjuvant Chemotherapy in Locally Advanced Cervical Cancer: A Tumor Response Score.
    Anticancer Res. 2021;41:3543-3560.
    PubMed         Abstract available


  5. ZHU C, Zhang C, Cui X, Wu J, et al
    Trichosanthin inhibits cervical cancer by regulating oxidative stress-induced apoptosis.
    Bioengineered. 2021;12:2779-2790.
    PubMed         Abstract available

  6. LIU XX, Bao QX, Li YM, Zhang YH, et al
    The promotion of cervical cancer progression by signal transducer and activator of transcription 1-induced up-regulation of lncRNA MEOX2-AS1 as a competing endogenous RNA through miR-143-3p/VDAC1 pathway.
    Bioengineered. 2021;12:3322-3335.
    PubMed         Abstract available

    BMC Public Health

  7. GUO M, Xu J, Du J
    Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis.
    BMC Public Health. 2021;21:1329.
    PubMed         Abstract available

    BMC Womens Health

  8. FRIEBEL-KLINGNER TM, Luckett R, Bazzett-Matabele L, Ralefala TB, et al
    Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana.
    BMC Womens Health. 2021;21:267.
    PubMed         Abstract available

    Cancer Causes Control

  9. VAZQUEZ-OTERO C, Martinez Tyson D, Vamos CA, Romero-Daza N, et al
    Arguments in favor of and against the HPV vaccine school-entry requirement in Puerto Rico: a content analysis of newspaper media.
    Cancer Causes Control. 2021;32:793-802.
    PubMed         Abstract available

    Cancer Cell Int

  10. YANG Y, Li Y, Qi R, Zhang L, et al
    Constructe a novel 5 hypoxia genes signature for cervical cancer.
    Cancer Cell Int. 2021;21:345.
    PubMed         Abstract available

  11. MENG D, Jin H, Zhang X, Yan W, et al
    Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer.
    Cancer Cell Int. 2021;21:362.
    PubMed         Abstract available

    Cancer Manag Res

  12. YAO Z, Shu L, Yi Y, Qiao L, et al
    Hsa_circRNA_000543 Predicts Poor Prognosis and Promotes Cervical Cancer Cell Progression Through Regulating miR-567/ZNF268 Axis.
    Cancer Manag Res. 2021;13:5211-5222.
    PubMed         Abstract available

    Cell Cycle

  13. HU C, Han Y, Zhu G, Li G, et al
    Kruppel-like factor 5-induced overexpression of long non-coding RNA DANCR promotes the progression of cervical cancer via repressing microRNA-145-3p to target ZEB1.
    Cell Cycle. 2021 Jul 8:1-14. doi: 10.1080/15384101.2021.1941625.
    PubMed         Abstract available


  14. HICKS ML, Mutombo A, YouYou TG, Anaclet MM, et al
    Building workforce capacity for the surgical management of cervical cancer in a fragile, low-income African nation-Democratic Republic of the Congo.
    Ecancermedicalscience. 2021;15:1232.
    PubMed         Abstract available

  15. MUNGO C, Barker E, Randa M, Ambaka J, et al
    Integration of cervical cancer screening into HIV/AIDS care in low-income countries: a moral imperative.
    Ecancermedicalscience. 2021;15:1237.
    PubMed         Abstract available

    Front Cell Dev Biol

  16. HOU J, Chen C, Hu Y, Gong Q, et al
    Identify Function of WASL in Prognosis of Cervical Cancer Based on Omics Data.
    Front Cell Dev Biol. 2021;9:670890.
    PubMed         Abstract available

    Front Cell Infect Microbiol

  17. MATTOSCIO D, Gheit T, Strati K, Venuti A, et al
    Editorial: HPV and Host Interaction.
    Front Cell Infect Microbiol. 2021;11:638005.

    Front Oncol

  18. ZHAO W, Xiao Y, Zhao W, Yang Q, et al
    Survival Outcomes in Patients With 2018 FIGO Stage IA2-IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis.
    Front Oncol. 2021;11:682849.
    PubMed         Abstract available

  19. BAO C, An N, Xie H, Xu L, et al
    Identifying Potential Neoantigens for Cervical Cancer Immunotherapy Using Comprehensive Genomic Variation Profiling of Cervical Intraepithelial Neoplasia and Cervical Cancer.
    Front Oncol. 2021;11:672386.
    PubMed         Abstract available

  20. ZHANG XR, Li ZQ, Sun LX, Liu P, et al
    Cohort Profile: Chinese Cervical Cancer Clinical Study.
    Front Oncol. 2021;11:690275.
    PubMed         Abstract available

    Front Public Health

  21. KHATIWADA M, Kartasasmita C, Mediani HS, Delprat C, et al
    Knowledge, Attitude and Acceptability of the Human Papilloma Virus Vaccine and Vaccination Among University Students in Indonesia.
    Front Public Health. 2021;9:616456.
    PubMed         Abstract available

    Gynecol Oncol

  22. SPONHOLTZ SE, Mogensen O, Hildebrandt MG, Schledermann D, et al
    Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
    Gynecol Oncol. 2021 Jul 2. pii: S0090-8258(21)00512.
    PubMed         Abstract available

  23. LEVINSON K, Beavis AL, Purdy C, Rositch AF, et al
    Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.
    Gynecol Oncol. 2021 Jun 30. pii: S0090-8258(21)00511.
    PubMed         Abstract available

    Health Commun

  24. MCFARLANE SJ, Morgan SE
    Evaluating Culturally-targeted Fear Appeal Messages for HPV Self-Sampling among Jamaican Women: A Qualitative Formative Research Study.
    Health Commun. 2021;36:877-890.
    PubMed         Abstract available

    Hum Reprod

  25. SKORSTENGAARD M, Lynge E, Napolitano G, Blaakaer J, et al
    Risk of precancerous cervical lesions in women using a hormone-containing intrauterine device and other contraceptives: a register-based cohort study from Denmark.
    Hum Reprod. 2021 May 11. pii: 6273654. doi: 10.1093.
    PubMed         Abstract available

    Hum Vaccin Immunother

  26. DUAN F, Chen J, Yao H, Wang Y, et al
    Enhanced therapeutic efficacy of Listeria-based cancer vaccine with codon-optimized HPV16 E7.
    Hum Vaccin Immunother. 2021;17:1568-1577.
    PubMed         Abstract available

  27. DANIELS V, Prabhu VS, Palmer C, Samant S, et al
    Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States.
    Hum Vaccin Immunother. 2021;17:1943-1951.
    PubMed         Abstract available

  28. MAI Q, Yang X, Cheng H, Wu G, et al
    Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China.
    Hum Vaccin Immunother. 2021;17:965-971.
    PubMed         Abstract available

  29. NYGARD M, Hansen BT, Kjaer SK, Hortlund M, et al
    Human papillomavirus genotype-specific risks for cervical intraepithelial lesions.
    Hum Vaccin Immunother. 2021;17:972-981.
    PubMed         Abstract available

  30. BIEDERMAN E, Donahue K, Sturm L, Champion V, et al
    The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their children.
    Hum Vaccin Immunother. 2021;17:1000-1005.
    PubMed         Abstract available

  31. ZHANG X, Wang Z, Ren Z, Li Z, et al
    HPV vaccine acceptability and willingness-related factors among Chinese adolescents: a nation-wide study.
    Hum Vaccin Immunother. 2021;17:1025-1032.
    PubMed         Abstract available

  32. TOZAWA-ONO A, Kamada M, Teramoto K, Hareyama H, et al
    Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study.
    Hum Vaccin Immunother. 2021;17:950-954.
    PubMed         Abstract available

  33. BHUYAN PK, Dallas M, Kraynyak K, Herring T, et al
    Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.
    Hum Vaccin Immunother. 2021;17:1288-1293.
    PubMed         Abstract available

  34. HU S, Xu X, Zhu F, Hong Y, et al
    Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial.
    Hum Vaccin Immunother. 2021;17:955-964.
    PubMed         Abstract available

  35. KJAER SK, Nygard M, Sundstrom K, Munk C, et al
    Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up.
    Hum Vaccin Immunother. 2021;17:943-949.
    PubMed         Abstract available

  36. WANG W, Lyu J, Li M, Zhang Y, et al
    Quality evaluation of HPV vaccine-related online messages in China: a cross-sectional study.
    Hum Vaccin Immunother. 2021;17:1089-1096.
    PubMed         Abstract available

    Indian J Gynecol Oncol

  37. WEI L, Xie X, Liu J, Qiao Y, et al
    Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China.
    Indian J Gynecol Oncol. 2021;19:51.
    PubMed         Abstract available

    Int J Clin Oncol

  38. OLTHOF EP, van der Aa MA, Adam JA, Stalpers LJA, et al
    The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature review.
    Int J Clin Oncol. 2021 Jul 9. pii: 10.1007/s10147-021-01980.
    PubMed         Abstract available

    Int J Gynecol Cancer

  39. SPENCER NM, Bos L
    Intracardiac metastatic cervical cancer.
    Int J Gynecol Cancer. 2021;31:1095.

    J Cancer

  40. YANG X, Siddique A, Khan AA, Wang Q, et al
    Chlamydia Trachomatis Infection: Their potential implication in the Etiology of Cervical Cancer.
    J Cancer. 2021;12:4891-4900.
    PubMed         Abstract available

    J Clin Microbiol

  41. DHILLON SK, Valencak AO, Xu L, Poljak M, et al
    Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework.
    J Clin Microbiol. 2021 Mar 17. pii: JCM.00286-21. doi: 10.1128/JCM.00286.
    PubMed         Abstract available

    J Med Screen

  42. FRANCK JE, Ringa V, Rigal L, Sassenou J, et al
    Patterns of gynaecological check-up and their association with body mass index within the CONSTANCES cohort.
    J Med Screen. 2021;28:10-17.
    PubMed         Abstract available

    J Microbiol Biotechnol

  43. LEE HJ, Park M, Choi H, Nowakowska A, et al
    Pine Needle Extract Applicable to Topical Treatment for the Prevention of Human Papillomavirus Infection.
    J Microbiol Biotechnol. 2021;31:137-143.
    PubMed         Abstract available

    J Minim Invasive Gynecol

  44. DIAZ-FEIJOO B, Acosta U, Torne A, Gil-Ibanez B, et al
    Laparoscopic debulking of enlarged pelvic nodes during surgical paraaortic staging in locally advanced cervical cancer: a retrospective comparative cohort study.
    J Minim Invasive Gynecol. 2021 Jul 1. pii: S1553-4650(21)00311.
    PubMed         Abstract available

    J Nanosci Nanotechnol

  45. WEN S, Xing W, Gao L, Zhao S, et al
    Effect of Superparamagnetic DMSO@gamma-Fe(2)O(3) Combined with Carmustine on Cervical Cancer.
    J Nanosci Nanotechnol. 2021;21:6196-6204.
    PubMed         Abstract available

    J Obstet Gynaecol Res

  46. ZHANG J, Dai Y, Leng J, Zhu L, et al
    Hysterectomy and bilateral adnexectomy using transvaginal natural orifice transluminal endoscopic surgery: The role of multichannel abdominal PORT and vaginal support ring.
    J Obstet Gynaecol Res. 2021;47:2521-2528.
    PubMed         Abstract available

  47. ORISAKA S, Nakamura M, Obata T, Iwadare J, et al
    A case of synchronous high-grade cervical intraepithelial neoplasia and metastatic squamous cell carcinomas of unknown primary in rectum.
    J Obstet Gynaecol Res. 2021;47:2555-2559.
    PubMed         Abstract available

  48. EBISAWA K, Sugiyama T, Itami M, Maru Y, et al
    A case of cervical clear cell carcinoma with serous component.
    J Obstet Gynaecol Res. 2021;47:2551-2554.
    PubMed         Abstract available

    J Oncol

  49. WASSIE M, Fentie B, Asefa T
    Determinants of Mortality among Cervical Cancer Patients Attending in Tikur Anbessa Specialized Hospital, Ethiopia: Institutional-Based Retrospective Study.
    J Oncol. 2021;2021:9916050.
    PubMed         Abstract available

    J Pharm Pharmacol

  50. CHEN R, He P
    Long noncoding RNA HOXA-AS2 accelerates cervical cancer by the miR-509-3p/BTN3A1 axis.
    J Pharm Pharmacol. 2021 Jul 8. pii: 6317732. doi: 10.1093.
    PubMed         Abstract available


  51. BENABOU K, Khadraoui W, Khader T, Hui P, et al
    Port-Site Metastasis in Gynecological Malignancies.
    JSLS. 2021;25.
    PubMed         Abstract available

    Lancet Public Health

  52. CASTANON A, Rebolj M, Burger EA, de Kok IMCM, et al
    Cervical screening during the COVID-19 pandemic: optimising recovery strategies.
    Lancet Public Health. 2021;6:e522-e527.
    PubMed         Abstract available

    Nan Fang Yi Ke Da Xue Xue Bao

  53. SUN Z, Hu J, Hu K, Tang M, et al
    [Role of long noncoding RNA SNHG3 in regulating proliferation, migration and invasion of cervical cancer SiHa cells].
    Nan Fang Yi Ke Da Xue Xue Bao. 2021;41:931-936.
    PubMed         Abstract available

    Oxid Med Cell Longev

  54. GONG G, Shen YL, Lan HY, Jin JM, et al
    The Cyr61 Is a Potential Target for Rotundifuran, a Natural Labdane-Type Diterpene from Vitex trifolia L., to Trigger Apoptosis of Cervical Cancer Cells.
    Oxid Med Cell Longev. 2021;2021:6677687.
    PubMed         Abstract available

    Panminerva Med

  55. QU L, Liu B, Bi X, Liu C, et al
    CLIC1 promotes the progression of cervical cancer through the PTEN / PI3K / AKT pathway.
    Panminerva Med. 2021 Jul 9. pii: S0031-0808.21.04430.

    PLoS One

  56. MOISE RK, Balise R, Ragin C, Kobetz E, et al
    Cervical cancer risk and access: Utilizing three statistical tools to assess Haitian women in South Florida.
    PLoS One. 2021;16:e0254089.
    PubMed         Abstract available

    Prev Med

  57. SMITH MA, Burger EA, Castanon A, de Kok IMCM, et al
    Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis.
    Prev Med. 2021;151:106623.
    PubMed         Abstract available

  58. DEGROFF A, Miller J, Sharma K, Sun J, et al
    COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.
    Prev Med. 2021;151:106559.
    PubMed         Abstract available

  59. WALKER MJ, Meggetto O, Gao J, Espino-Hernandez G, et al
    Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.
    Prev Med. 2021;151:106586.
    PubMed         Abstract available

  60. WENTZENSEN N, Clarke MA, Perkins RB
    Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities.
    Prev Med. 2021;151:106596.
    PubMed         Abstract available

  61. BASU P, Lucas E, Zhang L, Muwonge R, et al
    Leveraging vertical COVID-19 investments to improve monitoring of cancer screening programme - A case study from Bangladesh.
    Prev Med. 2021;151:106624.
    PubMed         Abstract available

  62. CAMPBELL C, Sommerfield T, Clark GRC, Porteous L, et al
    COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.
    Prev Med. 2021;151:106606.
    PubMed         Abstract available

  63. SAWAYA GF, Holt HK, Lamar R, Perron-Burdick M, et al
    Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California.
    Prev Med. 2021;151:106569.
    PubMed         Abstract available

    Prev Med Rep

  64. CYR PR, Pedersen K, Iyer AL, Bundorf MK, et al
    Providing more balanced information on the harms and benefits of cervical cancer screening: A randomized survey among US and Norwegian women.
    Prev Med Rep. 2021;23:101452.
    PubMed         Abstract available

    Public Health Nurs

  65. DSOUZA JP, Van den Broucke S, Pattanshetty S, Dhoore W, et al
    The application of health behavior theories to promote cervical cancer screening uptake.
    Public Health Nurs. 2021 Jul 7. doi: 10.1111/phn.12944.
    PubMed         Abstract available

    Reprod Health

  66. SUMARMI S, Hsu YY, Cheng YM, Lee SH, et al
    Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
    Reprod Health. 2021;18:138.
    PubMed         Abstract available

    Sci Rep

  67. MENDOZA RP, Haidary T, Gabutan E, Zhou YY, et al
    Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer.
    Sci Rep. 2021;11:14064.
    PubMed         Abstract available

    Support Care Cancer

  68. KPOGHOMOU MA, Geneau M, Menard J, Stiti M, et al
    Assessment of an onco-sexology support and follow-up program in cervical or vaginal cancer patients undergoing brachytherapy.
    Support Care Cancer. 2021;29:4311-4318.
    PubMed         Abstract available

    Tohoku J Exp Med

  69. TOYOSHIMA M, Shimada M, Sasaki S, Ishibashi M, et al
    A Single Arm Prospective Pilot Study Examining the Efficacy and Safety of Bevacizumab Single Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Advanced or Recurrent Cervical Cancer.
    Tohoku J Exp Med. 2021;254:145-153.
    PubMed         Abstract available


  70. LALISCIA C, Gadducci A, Mattioni R, Orlandi F, et al
    MRI-based radiomics: promise for locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
    Tumori. 2021 Jul 8:3008916211014274. doi: 10.1177/03008916211014274.
    PubMed         Abstract available


  71. CHU H, Ko LK, Ibrahim A, Bille Mohamed F, et al
    The impact of an educational forum intervention on East African mothers' HPV vaccine-related knowledge, attitudes, and intentions to vaccinate their adolescent children.
    Vaccine. 2021 May 27. pii: S0264-410X(21)00593.
    PubMed         Abstract available

  72. GLENN BA, Nonzee NJ, Tieu L, Pedone B, et al
    Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00454.
    PubMed         Abstract available

    Womens Health (Lond)

  73. KOHLER RE, Roncarati JS, Aguiar A, Chatterjee P, et al
    Trauma and cervical cancer screening among women experiencing homelessness: A call for trauma-informed care.
    Womens Health (Lond). 2021;17:17455065211029238.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.